Luminex announces initiation of clinical trials for ARIES® clostridium difficile assay
Luminex announced that testing at the clinical trial sites for the ARIES® HSV 1&2 Assay is now complete. The next steps, including site to site reproducibility testing, followed by data analysis and assembly of the data package for submission to the FDA, are now underway. April 27, 2015